Alternative Data for Quest Diagnostics
About Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses.
| Price | $184.24 |
| Target Price | Sign up |
| Volume | 667,840 |
| Market Cap | $20.2B |
| Year Range | $164.95 - $191.5 |
| Dividend Yield | 1.73% |
| PE Ratio | 21.22 |
| Analyst Rating | 75% buy |
| Earnings Date | February 10 '26 |
| Industry | Health Care Services |
In the news
 |
A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price WeaknessJanuary 26 - Yahoo |
|
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive YearJanuary 21 - Yahoo |
 |
Guardant Health Projects 33% Growth on Quest Diagnostics PactJanuary 18 - Edgen.tech |
|
3 Reasons to Sell DGX and 1 Stock to Buy InsteadJanuary 13 - Yahoo |
 |
Quest Diagnostics targets about $1.0B in dividend over 2025-2027 periodJanuary 12 - Thefly.com |
 |
Quest Diagnostics Incorporated (DGX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 12 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 2.82B | 1.87B | 949M | 245M | 547M | 2.600 |
| Q2 '25 | 2.76B | 1.82B | 943M | 282M | 596M | 2.620 |
| Q1 '25 | 2.65B | 1.79B | 863M | 220M | 488M | 2.210 |
| Q4 '24 | 2.62B | 1.76B | 858M | 222M | 507M | 2.230 |
| Q3 '24 | 2.49B | 1.68B | 811M | 226M | 479M | 2.300 |
Insider Transactions View All
| Gregg Vicky B filed to sell 17,037 shares at $191.8. November 28 '25 |
| Davis J. E. filed to sell 125,227 shares at $192.3. November 28 '25 |
| Davis J. E. filed to sell 120,480 shares at $193. November 28 '25 |
| Davis J. E. filed to sell 166,231 shares at $191.6. November 28 '25 |
| DELANEY MARK E filed to sell 7,530 shares at $187.4. November 20 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson |
Dec 12, 25 | Sell | $1K - $15K |
| Gil Cisneros |
Feb 12, 25 | Sell | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
Read more about Quest Diagnostics (DGX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Quest Diagnostics
The Market Cap of Quest Diagnostics is $20.2B.
As of today, Quest Diagnostics' PE (Price to Earnings) ratio is 21.22.
Quest Diagnostics will report its next earnings on February 10 '26.
Currently, the price of one share of Quest Diagnostics stock is $184.24.
The DGX stock price chart above provides a comprehensive visual representation of Quest Diagnostics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Quest Diagnostics shares. Our platform offers an up-to-date DGX stock price chart, along with technical data analysis and alternative data insights.
Yes, Quest Diagnostics (DGX) offers dividends to its shareholders, with a dividend yield of 1.73%. This dividend yield represents Quest Diagnostics' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Quest Diagnostics in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Quest Diagnostics are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
